Skip to main content

Advertisement

Table 1 Baseline characteristics

From: Evaluation of etoricoxib in patients undergoing total knee replacement surgery in a double-blind, randomized controlled trial

  Placebo Etoricoxib 90 mg  Etoricoxib 120 mg Ibuprofen 1800 mg
  N = 98 N = 224 N = 230 N = 224
Female n (%) 56 (57.1) 134 (59.8) 139 (60.4) 152 (67.9)
Age     
Mean [yr (SD)] 65.2 (7.9) 65.7 (8.5) 64.7 (8.1) 66.0 (8.1)
Median 64.5 66.0 64.0 66.0
Range 43 - 81 37 - 84 44 - 86 38 – 84
Height in cm (SD) 167.1 (10.6) 166.9 (10.8) 168.1 (10.6) 165.8 (10.6)
Body Weight in kg (SD) 85.9 (17.3) 86.2 (17.6) 85.4 (16.2) 84.4 (16.6)
Body Mass Index (SD) 30.6 (4.7) 30.8 (5.0) 30.2 (4.7) 30.6 (4.7)
Duration of Surgery in hours (SD) 1.4 (0.5) 1.4 (0.5) 1.4 (0.5) 1.4 (0.5)
Baseline Pain Intensity at Rest NRS (SD)     
Mean Score (SD) 7.1 (1.8) 7.0 (1.8) 7.1 (1.8) 6.9 (1.7)
Mild Pain (Score: 0–4) n (%) 0 (0.0) 1 (0.4) 0 (0.0) 1 (0.4)
Moderate Pain (Score 5–7) n (%) 60 (61.2) 137 (61.2) 135 (58.7) 140 (62.2)
Severe Pain (Score 8–10) n (%) 38 (38.8) 85 (37.9) 94 (40.9) 83 (37.1)
Anesthesia Type n (%)     
 General 38 (38.8) 83 (37.1) 90 (39.1) 81 (36.2)
 Spinal 60 (61.2) 141 (62.9) 140 (60.9) 142 (63.4)
 Other 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.4)